I
Integra LifeSciences Holdings Corporation (IART)
NMS – Real Time Price. Currency in USD
13.77
-0.20 (-1.43%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
13.77
-0.20 (-1.43%)
At close: May 12, 2026, 4:00 PM EDT
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
| Name | Position |
|---|---|
| Christopher Ward | Senior Director of Investor Relations |
| Dr. Stuart M. Essig Ph.D. | CEO, President & Chairman |
| Laurene Isip | Vice President of Global Corporate Communications & Public Relations |
| Mr. Harvinder Pal Singh | Executive VP & President of International Business |
| Mr. Jeffrey A. Mosebrook | Senior VP of Finance & Principal Accounting Officer |
| Mr. Michael D. Hutchinson | Executive VP, Chief Legal Officer & Secretary |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | S-8 | forms-8.htm |
| 2026-05-08 | 8-K | iart-20260507.htm |
| 2026-05-05 | DEFA14A | proxysupplement5-5x26.htm |
| 2026-05-05 | 8-K | iart-20260505.htm |
| 2026-04-15 | 8-K | iart-20260410.htm |
| 2026-04-06 | DEF 14A | iart-20260406.htm |
| 2026-02-26 | S-3ASR | d117422ds3asr.htm |
| 2025-12-12 | 8-K | iart-20251211.htm |
| 2025-10-30 | 8-K | iart-20251030.htm |
| 2025-07-31 | S-8 | iart73125is8.htm |
| Mr. Michael J. McBreen | Chief Commercial Officer |
| Mr. Robert T. Davis Jr. | Executive VP & President of Tissue Technologies |
| Mr. Teshtar Elavia | Corporate VP & Chief Technology Officer |
| Ms. Lea Daniels Knight | Executive VP & CFO |